Literature DB >> 9059879

Host MHC class I gene control of NK-cell specificity in the mouse.

P Höglund1, J Sundbäck, M Y Olsson-Alheim, M Johansson, M Salcedo, C Ohlén, H G Ljunggren, C L Sentman, K Kärre.   

Abstract

The missing self model predicts that NK cells adapt somatically to the type as well as levels of MHC class I products expressed by their host. Transgenic and gene knock-out mice have provided conclusive evidence that MHC class I genes control specificity and tolerance of NK cells. The article describes this control and discusses the possible mechanisms behind it, starting from a genetic model to study how natural resistance to tumors is influenced by MHC class I expression in the host as well as in the target cells. Data on host gene regulation of NK-cell functional specificity as well as Ly49 receptor expression are reviewed, leading up to the central question: how does the system develop and maintain "useful" NK cells, while avoiding "harmful" and "useless" ones? The available data can be fitted within each of two mutually none-exclusive models: cellular adaptation and clonal selection. Recent studies supporting cellular adaptation bring the focus on different possibilities within this general mechanism, such as anergy, receptor calibration and, most importantly, whether the specificity of each NK cell is permanently fixed or subject to continuous regulation.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9059879     DOI: 10.1111/j.1600-065x.1997.tb00936.x

Source DB:  PubMed          Journal:  Immunol Rev        ISSN: 0105-2896            Impact factor:   12.988


  20 in total

1.  Major histocompatibility complex (MHC) class I KbDb -/- deficient mice possess functional CD8+ T cells and natural killer cells.

Authors:  Y Vugmeyster; R Glas; B Pérarnau; F A Lemonnier; H Eisen; H Ploegh
Journal:  Proc Natl Acad Sci U S A       Date:  1998-10-13       Impact factor: 11.205

2.  Control of murine cytomegalovirus in the lungs: relative but not absolute immunodominance of the immediate-early 1 nonapeptide during the antiviral cytolytic T-lymphocyte response in pulmonary infiltrates.

Authors:  R Holtappels; J Podlech; G Geginat; H P Steffens; D Thomas; M J Reddehase
Journal:  J Virol       Date:  1998-09       Impact factor: 5.103

3.  Multiplicity and plasticity of natural killer cell signaling pathways.

Authors:  Sabrina Chiesa; Michael Mingueneau; Nicolas Fuseri; Bernard Malissen; David H Raulet; Marie Malissen; Eric Vivier; Elena Tomasello
Journal:  Blood       Date:  2005-11-15       Impact factor: 22.113

4.  Impact of Mixed Xenogeneic Porcine Hematopoietic Chimerism on Human NK Cell Recognition in a Humanized Mouse Model.

Authors:  H W Li; P Vishwasrao; M A Hölzl; S Chen; G Choi; G Zhao; M Sykes
Journal:  Am J Transplant       Date:  2016-08-10       Impact factor: 8.086

Review 5.  Generating pluripotent stem cells: differential epigenetic changes during cellular reprogramming.

Authors:  Stacey C Tobin; Kitai Kim
Journal:  FEBS Lett       Date:  2012-07-20       Impact factor: 4.124

6.  The putative natural killer decoy early gene m04 (gp34) of murine cytomegalovirus encodes an antigenic peptide recognized by protective antiviral CD8 T cells.

Authors:  R Holtappels; D Thomas; J Podlech; G Geginat; H P Steffens; M J Reddehase
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

Review 7.  Participation of innate and acquired immunity in atherosclerosis.

Authors:  L K Curtiss; N Kubo; N K Schiller; W A Boisvert
Journal:  Immunol Res       Date:  2000       Impact factor: 2.829

Review 8.  Concise review: parthenote stem cells for regenerative medicine: genetic, epigenetic, and developmental features.

Authors:  Brittany Daughtry; Shoukhrat Mitalipov
Journal:  Stem Cells Transl Med       Date:  2014-01-17       Impact factor: 6.940

9.  NK cell responsiveness is tuned commensurate with the number of inhibitory receptors for self-MHC class I: the rheostat model.

Authors:  Nathalie T Joncker; Nadine C Fernandez; Emmanuel Treiner; Eric Vivier; David H Raulet
Journal:  J Immunol       Date:  2009-04-15       Impact factor: 5.422

Review 10.  KIR-HLA intercourse in HIV disease.

Authors:  Mary Carrington; Maureen P Martin; Jeroen van Bergen
Journal:  Trends Microbiol       Date:  2008-10-29       Impact factor: 17.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.